<?xml version="1.0"?>
<!--N/U marks fields that are not used by when importing to the RECLAC platform-->
<trials>
    <trial>
        <main>
            <trial_id>IRCT138708271460N1</trial_id> <!--becomes secondary id-->
            <reg_name>IRCT</reg_name>               <!--becomes secondary id-->
            <date_registration>2009-02-16</date_registration> <!--N/U-->
            <primary_sponsor>Tabriz Univ Med Sci</primary_sponsor>
            <public_title reclac:lang="en">
                Comparison of Ascorbic Acid and Grape Seed Extract in 
                Oxidative Stress Induced by on Pump Heart Surgery
            </public_title>
            <acronym></acronym>
            <scientific_title reclac:lang="en">
                Effect of Ascorbic Acid and Grape Seed Extract 
                "Vitis Vinifera L." on Oxidative Stress Induced by on Pump 
                Coronary Artery by Pass Grafting Surgery
            </scientific_title>
            <date_enrolment>2008-11-01</date_enrolment>
            <type_enrolment>anticipated</type_enrolment>
            <target_size>75</target_size>
            <recruitment_status>Complete</recruitment_status> <!--inconsistent with date and type of enrolment-->
            <url>http://www.irct.ir/searchresult.php?id=1460&amp;number=1</url> <!--N/U-->
            <study_type>interventional</study_type>
            <study_design reclac:lang="en">
                Randomization: randomized.
                Blinding:  Double blind.
                Placebo: not used.
                Assignment: Parallel.
                Purpose: Supportive care.
                Other design features:
            </study_design>
            <phase>2-3</phase>
            <hc_freetext reclac:lang="en">
                Condition 1: Coronary Atrery Bypass Graft (CABG).
                Condition 2: Atherosclerotic heart disease.
                Condition 3: Ischaemic cardiomyopathy.
            </hc_freetext>
            <i_freetext reclac:lang="en">
                Intervention 1: Control Group: without intervention.
                Intervention 2: Grape Seed Extract 100 mg/6h.
                Intervention 3: Vit C 25 mg/kg.
            </i_freetext>
        </main>
        <contacts>
            <contact>
                <type>public</type>
                <firstname>Naser safaei, MD, Surgeon</firstname>
                <middlename/>
                <lastname/>
                <address>Tabriz Univ Med Sci</address>
                <city>Tabriz</city>
                <country1>Iran, Islamic Republic Of</country1>
                <zip>51656-65811</zip>
                <telephone>+98-411-3357767</telephone>
                <email>drsafaei@yahoo.com</email>
                <affiliation>Tabriz Univ Med Sci</affiliation>
            </contact>
            <contact>
                <type>scientific</type>
                <firstname>Dr Naser Safaei</firstname>
                <middlename/>
                <lastname/>
                <address>Daneshgah St,Tabriz Univ Med Sci</address>
                <city>Tabriz</city>
                <country1>Iran, Islamic Republic Of</country1>
                <zip>51656-65811</zip>
                <telephone>+98-411-3357767</telephone>
                <email>drsafaei@yahoo.com</email>
                <affiliation>Tabriz Univ Med Sci</affiliation>
            </contact>
            <!-- also: type=site for site contacts, one per site in the country
                 hosting the registry-->
        </contacts>
        <countries>
            <country2>Iran, Islamic Republic Of</country2>
        </countries>
        <criteria>
            <inclusion_criteria reclac:lang="en">
                Candidates for elective CABG surgery 
                with pump for first time, 3 Vessel Disease (3VD).
            </inclusion_criteria>
            <exclusion_criteria reclac:lang="en">
                High risk patients, Those who need another 
                heart surgery beside CABG, Urgent patients Diabetics, Ischemic 
                time more than 120 min.
            </exclusion_criteria>
            <agemin>0</agemin>
            <reclac:agemin_unit>no limit</reclac:agemin_unit>
            <agemax>150</agemax>
            <reclac:agemin_unit>no limit</reclac:agemin_unit>
            <gender>both</gender>
        </criteria>
        <health_condition_code>
            <hc_code/>
        </health_condition_code>
        <health_condition_keyword>
            <hc_keyword reclac:vocabulary="DeCS" reclac:code="C14.280.647">
                    Myocardial Ischemia
            </hc_keyword>
            <hc_keyword>Atherosclerotic heart disease</hc_keyword>
            <hc_keyword>Ischaemic cardiomyopathy</hc_keyword>
        </health_condition_keyword>
        <intervention_code>
            <i_code>Not applicable</i_code>
            <i_code>Treatment: drugs</i_code>
            <i_code>Treatment: drugs</i_code>
            <i_code></i_code>
        </intervention_code>
        <intervention_keyword>
            <i_keyword></i_keyword>
        </intervention_keyword>
        <primary_outcome>
            <prim_outcome>
                Left Ventricular Ejection Fraction (LVEF).
                Timepoint: Before and after CABG. 
                Method of measurement: Trans Thoracic Echocardiography (TTE)
            </prim_outcome>
        </primary_outcome>
        <secondary_outcome>
            <sec_outcome>
                Total Antioxidant Capacity (TAC).
                Timepoint: Before, middle and after CABG.
                Method of measurement: Biochemistry (blood sample)
            </sec_outcome>
        </secondary_outcome>
        <secondary_sponsor>
            <sponsor_name></sponsor_name>
        </secondary_sponsor>
        <secondary_ids>
            <secondary_id>
                <sec_id>NCT00839085</sec_id>
                <issuing_authority>ClinicalTrials.gov</issuing_authority>
            </secondary_id>
        </secondary_ids>
        <source_support>
            <source_name>Tabriz University of Medical Sciences</source_name>
        </source_support>
    </trial>
</trials>
